Reduced-Intensity (FB2) Vs Reduced-Toxicity Myeloablative (FB3/FB4) Fludarabine/Busulfan Based Conditioning Regimens for Non-Hodgkin Lymphoma (NHL) Allografted Adult Patients: A Retrospective Study on Behalf of the Francophone Society of Bone Marrow Trans

Affiliation auteurs!!!! Error affiliation !!!!
TitreReduced-Intensity (FB2) Vs Reduced-Toxicity Myeloablative (FB3/FB4) Fludarabine/Busulfan Based Conditioning Regimens for Non-Hodgkin Lymphoma (NHL) Allografted Adult Patients: A Retrospective Study on Behalf of the Francophone Society of Bone Marrow Trans
Type de publicationJournal Article
Year of Publication2016
AuteursLe Bourgeois A, Labopin M, Blaise D, Ceballos P, Vigouroux S, de Latour RPeffault, Suarez F, Deconick E, Chantepie S, Bay J-O, Bulabois C-E, Daguindau E, Contentin N, Yakoub-Agha I, Cornillon J, Francois S, Turlure P, Charbonnier A, Rohrlich P-S, Nguyen S, Maillard N, Marchand T, Mohty M, Chevallier P
JournalBLOOD
Volume128
Date PublishedDEC 2
Type of ArticleMeeting Abstract
ISSN0006-4971
DOI10.1182/blood.V128.22.980.980